Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75

Breast Cancer Research and Treatment

Volumn 94, Issue 2, 2005, Pages 171-183

  Carvajal, A ^a   Espinoza, N ^a   Kato, S ^a   Pinto, M ^a   Sadarangani, A ^a   Monso, C ^a   Aranda, E ^a   Villalon, M ^a   Richer, J K ^b   Horwitz, K B ^b   Brosens, J J ^c   Owen, G I ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF COLORADO   (United States)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

c fos; EGFR; erk; HRT; Progestin; STAT5

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROGESTERONE;

ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIGAND BINDING; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHOSPHORYLATION; PROGESTERONE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 27544510660     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-7726-6     Document Type: Article

References (47)

1. D Graham C Clarke 1997 Physiological action of progesterone in target tissues Endocrine Rev 18 502 519
2. OM Conneely DM Kettelberger MJ Tsai WT Schrader BW O'Malley 1989 The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event J Biol Chem 264 14062 14064
3. DL Bain MA Franden JL [tmp] McManaman GS Takimoto KB Horwitz 2001 The N -terminal region of human progesterone B-receptors: biophysical and biochemical comparison to A-receptors J Biol Chem. 276 23825 23831
4. JP Lydon FJ DeMayo CR Funk SK Mani AR Hughes CA Montgomery Jr G Shyamala OM Conneely BW O'Malley 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities Genes Dev 9 2266 2278
5. G Beatson 1896 On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment will illustrative cases Lancet ii 104 107
6. I Peerson E Wliderpass L Bergkrist R Bergtrom C Schairer 1999 Risk of breast and endometrial cancer after estradiol and estradiol-progestine replacement Cancer Causes Control 10 253 260
7. C Schairer J Lubin R Troisi S Sturgeon L Brinton R Hoover 2000 Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk JAMA 283 485 491
8. RT Chlebowski SL Hendrix RD Langer ML Stefanick M Gass D Lane RJ Rodabough MA Gilligan MG Cyr CA Thomson J Khandekar H Petrovitch A [tmp] McTiernan WHI Investigators 2003 Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial JAMA 289 3243 3253
9. TJ Key PK Verkasalo E Banks 2001 Epidemiology of breast cancer Lancet Oncol 2 133 140
10. W Catherino M Jeng V Jordan 1993 Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism Br J Cancer 67 945 952
11. PJ Weiler JP Wiebe 2000 Plasma membrane receptors for the cancer-regulating progesterone metabolites, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-4-pregnen-20-one in MCF-7 breast cancer cells Biochem Biophys Res Commun 272 731 737
12. M Montecchia C Lamb A Molinolo I Luthy P Pazos E Charreau S Vanzulli C Lanari 1999 Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas J Steroid Biochem Mol Biol 68 11 21
13. J Wiesen P Young G Werb G Cunha 1999 Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development Development 126 335 344
14. PJ Miettinen JE Berger J Meneses Y Phung RA Pedersen Z Werb R Derynck 1995 Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor Nature 376 337 341
15. R Jorissen F Walker N Pouliot T Garrett C Ward A Burgess 2003 Epidermal growth factor receptor: mechanisms of activation and signaling Exp Cell Res 284 31 53
16. SB Fox AL Harris 1997 The epidermal growth factor receptor in breast cancer J Mammary Gland Biol Neoplasia 2 131 141
17. N Normanno F Ciardiello 1997 EGF-related peptides in the pathophysiology of the mammary gland J Mammary Gland Biol Neoplasia 2 143 151
18. PM Navolanic LS Steelman JA [tmp] McCubrey 2003 EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review) Int J Oncol 22 237 252
19. S Groshong G Owen B Grimison I Schauer M Todd T Langan R Sclafani C Lange K Horwitz 1997 Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1) Mol Endocrinol 11 1593 1607
20. J Richer N Lange N Manning G Owen R Powell K Horwitz 1998 Convergence of progesterone with growth factor and cytokine signaling in breast cancer J Biol Chem 273 31317 31326
21. CA Lange JK Richer KB Horwitz 1999 Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals Mol Endocrinol 13 829 836
22. C Lange J Richer T Shen K Horwitz 1998 Convergence of progesterone and epidermal growth factor signaling in breast cancer J Biol Chem 273 31308 31316
23. C Lange 2004 Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word? Mol Endocrinol 18 269 278
24. LC Murphy LJ Murphy D Dubik GI Bell RP Shiu 1998 Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins Cancer Res 48 4555 4560
25. HS Earp TL Dawson X Li H Yu 1995 Heterodimerization and functional interaction between EGF receptor family members: a new signalling paradigm with implications for breast cancer research Breast Cancer Res Treat 35 115 132
26. S Menard M Fortis F Castiglioni R Agresti A Balsari 2001 HER2 as a prognostic factor in breast cancer Oncology 61 67 72
27. R Santen R Song R [tmp] McPherson R Kumar L Adam M Jeng W Yue 2002 The role of mitogen-activated protein (MAP) kinase in breast cancer J Steoid Biochem Mol Biol 80 239 256
28. CA Sartorius SD Groshong LA Miller RL Powell L Tung GS Takimoto KB Horwitz 1994 New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP Cancer Res 54 3868 3877
29. V Calò M Migliavacca V Bazan M Macaluso M Buscemi N Gebbia A Russo 2003 STAT proteins: from normal control of cellular events to tumorigenesis J Cell Physiol 197 157 168
30. L Hennighausen GW Robinson KU Wagner XJ Liu 1997 Developing a mammary gland is a STAT affair Mammary Gland Biol Neoplasia. 2 365 372
31. JA Philp TG Burdon CJ Watson 1996 Differential activation of STATs 3 and 5 during mammary gland development FEBS Lett 396 77 80
32. E Iavnilovitch B Groner I Barash 2002 Overexpression and forced activation of STAT5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis Mol Cancer Res 1 32 47
33. J Richer B Jacobsen N Manning G Abel D Wolf K Horwitz 2002 Differential gene regulation by the two progesterone receptor isoforms un human breast cancer cells J Biol Chem 277 5209 5218
34. CS Hill R Treisman 1995 Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors EMBO J 14 5037 5047
35. DW Kim V Cheriyath AL Roy BH Cochran 1998 TFII-I enhances activation of the c-fos promoter through interactions withupstream elements Mol Cell Biol 18 3310 3320
36. K Milde-Langosch H Roder B Andritzky B Aslan G Hemminger A Brinkmann CM Bamberger T Loning AM Bamberger 2004 The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas Breast Cancer Res Treat 86 139 152
37. EA Musgrove CS Lee RL Sutherland 1991 Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes Mol Cell Biol 11 5032 5043
38. LW Engel NA Young TS Tralka ME Lippman SJ O'Brien MJ Joyce 1978 Establishment and characterization of three new continuous cell lines derived from human breast carcinomas Cancer Res 38 3352 3364
39. WAF1 cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300 J Biol Chem 273 10696 10701
40. L Murphy R Sutherland B Stead LC Murphy L Lazarus 1986 Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells Cancer Res 46 728 734
41. MA Wilson SA Chrysogelos 2002 Identification and characterization of a negative regulatory element within the epidermal growth factor receptor gene first intron in hormone-dependent breast cancer cells J Cell Biochem 85 601 614
42. T Holbro G Civenni N Hynes 2003 The ErbB receptors and their role in cancer progression Exp Cell Res 284 99 110
43. HS Wiley 2003 Trafficking of the ErbB receptors and its influence on signaling Exp Cell Res 284 78 88
44. K [tmp] McBride G Banninger C [tmp] McDonald N Reich 2002 Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-α EMBO J 21 1754 1763
45. E Stocklin M Wissler F Gouilleux B Groner 1996 Functional interactions between Stat5 and the glucocorticoid receptor Nature 383 726 728
46. L Björnström E Kilic M Norman M Parker M Sjoberg 2001 Cross-talk between STAT5b and estrogen receptor-α and -β in mammary epithelial cells J Mol Endocrinol 27 93 106
47. H Pang BG Rowan M Al-Dhaheri LE Faber 2004 Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells Breast Cancer Res 6 R239 R245